Qing-Nan Tang Selected Research

Neoplasms (Cancer)

2/2021	The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort.
1/2019	Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
1/2019	Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
1/2019	Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.
12/2018	Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
12/2018	Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
7/2018	Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing-Nan Tang Research Topics

Disease

32	Nasopharyngeal Carcinoma 01/2023 - 01/2018
9	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2018
7	Neoplasms (Cancer) 02/2021 - 07/2018
1	Disease Progression 12/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Necrosis 01/2019
1	Lymphadenopathy 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018
1	Venous Thromboembolism 12/2018
1	Neutropenia 12/2018
1	Leukopenia 12/2018
1	Anorexia 01/2018
1	Nausea 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Vomiting 01/2018
1	Ototoxicity 01/2018

Drug/Important Bio-Agent (IBA)

13	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 07/2018
5	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 01/2018
2	ChemokinesIBA 01/2023 - 01/2020
2	LigandsIBA 01/2023 - 01/2020
2	nedaplatinIBA 12/2021 - 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021
1	angiogeninIBA 01/2021
1	Viral DNAIBA 01/2019
1	AnticoagulantsIBA 12/2018
1	Taxoids (Taxanes)IBA 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 12/2018
1	Docetaxel (Taxotere)FDA Link 12/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2018
1	C-Reactive ProteinIBA 07/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2018
1	Biomarkers (Surrogate Marker)IBA 07/2018

Therapy/Procedure

13	Radiotherapy 02/2021 - 01/2018
10	Chemoradiotherapy 10/2022 - 01/2018
8	Drug Therapy (Chemotherapy) 02/2021 - 01/2019
6	Induction Chemotherapy 12/2021 - 10/2018
5	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2021 - 01/2018
2	Neck Dissection (Radical Neck Dissection) 01/2019 - 01/2018
2	Therapeutics 01/2019 - 07/2018
1	Re-Irradiation 01/2020
1	Adjuvant Chemotherapy 01/2019
1	Neoadjuvant Therapy 01/2019
1	Catheters 12/2018